You are here

P&T® Journal contents for February 2009

Features

Commentary
With a new administration in place, pharmacists may play a larger advisory role.
Stephen Barlas
The AURA tool enables health plans to evaluate quality and use of resources for their members with asthma by analyzing medical and pharmacy claims.
James H. Jackson, PharmD, MPH; Benjamin Gutierrez, PhD; Orsolya E. Lunacsek, PhD, MBA; and Sulabha Ramachandran, PhD
Products include fospropofol for se­dation; plerixafor to prepare patients for transplantation; and fenofibric acid for improving triglycerides and cholesterol.
Marvin M. Goldenberg, PhD, RPh, MS
Meeting Highlights
The authors report on a project to sequence the genomes of more than 1,000 people; Gaucher’s disease; warfarin genetics; and Huntington’s disease.
Safiya Abouzaid, PharmD; Joseph E. Couto, PharmD, MBA; and Marc B. Royo
Meeting Highlights
Topics include leukemias, myelodysplastic disorder, multiple myeloma, paroxysmal nocturnal hemoglobinuria, and idiopathic thrombocytopenic purpura.
Walter Alexander
Meeting Highlights
Summaries discuss zoledronic acid, everolimus, lapatinib, and letrozole.
Walter Alexander
Book Review
Third edition of a classic psychopharmacology text
Reviewed by David A. Casey, MD

Departments

Editorial
David B. Nash, MD, MBA, describes the goals of the National Quality Forum in improving health care in six key areas as well as eliminating unnecessary services.
David B. Nash, MD, MBA
Medication Errors
Is Glacial Acetic Acid Really Needed?
Matthew Grissinger, RPh, FASCP, explains how patients can be harmed when glacial (pure) acetic acid, instead of a diluted form, is dispensed.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Stephen Barlas discusses the long-simmering debate over the content of consumer medication information.
Stephen Barlas
From Mozobil to Zolpimist, P&T presents the latest studies and information about FDA approvals, new indications, recalls, and industry updates.
Drug Forecast
Hoyee Leong, PhD, and Mary Ellen Bonk, PharmD, review bendamustine (Treanda), a therapy for chronic lymphocytic leukemia.
Hoyee Leong, PhD, and Mary Ellen Bonk, PharmD